Devyser wins tender in Italy worth approximately SEK 5.7 million – doubling test volumes compared with previous agreement
Devyser Diagnostics AB, through its Italian subsidiary, has been awarded a renewed tender by...
Podcast | December 6, 2022
Contact an expert at Devyser
If you have a question, feel free to send us a message. One of our team members will get in touch with you as soon as possible.
Devyser extends its transplant test to heart and lung patients
Devyser announced that One Lambda™ Devyser Accept cfDNA, its test for monitoring kidney transplant...
Devyser signs first commercial reagent rental agreement under Illumina collaboration in Italy
Devyser, a global leader in advanced molecular diagnostics, today announced the first commercial...
-1.png)
Devyser announced the launch of next generation chimerism analysis solution, strengthening its offering in post-transplant monitoring
One Lambda™ Devyser Chimerism Plus is a next generation solution for chimerism analysis following...